loading
前日終値:
$1.52
開ける:
$1.59
24時間の取引高:
28,312
Relative Volume:
0.05
時価総額:
$3.67M
収益:
-
当期純損益:
$-4.69M
株価収益率:
-0.4405
EPS:
-3.7
ネットキャッシュフロー:
$-3.81M
1週間 パフォーマンス:
+0.62%
1か月 パフォーマンス:
-18.50%
6か月 パフォーマンス:
-32.92%
1年 パフォーマンス:
-45.30%
1日の値動き範囲:
Value
$1.57
$1.79
1週間の範囲:
Value
$1.4501
$1.79
52週間の値動き範囲:
Value
$1.31
$4.42

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Name
名前
Lixte Biotechnology Holdings Inc
Name
セクター
Healthcare (1195)
Name
電話
310 203 2902
Name
住所
248 ROUTE 25A, EAST SETAUKET
Name
職員
4
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
LIXT's Discussions on Twitter

LIXT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
LIXT 1.63 3.67M 0 -4.69M -3.81M -3.70
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Lixte Biotechnology Holdings Inc (LIXT) 最新ニュース

pulisher
Nov 15, 2024

LIXTW (Lixte Biotechnology Holdings) Accounts Payable & Acc - GuruFocus.com

Nov 15, 2024
pulisher
Oct 29, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving PremarketVF (NYSE:VFC) - Benzinga

Oct 29, 2024
pulisher
Oct 28, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com

Oct 23, 2024
pulisher
Oct 09, 2024

Lixte Biotechnology Holdings Inc WT (LIXTW-Q) QuotePress Release - The Globe and Mail

Oct 09, 2024
pulisher
Oct 01, 2024

Omeros (OMER) Shares Drop 5.04% Amid Financial Struggles - GuruFocus.com

Oct 01, 2024
pulisher
Oct 01, 2024

MRVI Stock Drops 5.11% Amid Financial Report Release - GuruFocus.com

Oct 01, 2024
pulisher
Sep 24, 2024

Lixte Biotechnology (NASDAQ:LIXT) Stock Price Down 2.1% - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy - GlobeNewswire

Sep 24, 2024
pulisher
Sep 23, 2024

Should investors be concerned about LYT’s high price-to-sales ratio? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Lilium (NASDAQ:LILM) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Pacer Advisors Inc. Has $16.07 Million Stock Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Renaissance Technologies LLC Sells 2,000 Shares of LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Texas Permanent School Fund Corp Trims Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

First Eagle Investment Management LLC Increases Stake in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Huber Capital Management LLC Acquires 241,814 Shares of Lyft, Inc. (NASDAQ:LYFT) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Acadian Asset Management LLC Cuts Position in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Quest Partners LLC Invests $28,000 in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Investors who lost money with shares of Liquidia Corporation - openPR

Sep 19, 2024
pulisher
Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - Kilgore News Herald

Sep 18, 2024
pulisher
Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024
pulisher
Sep 10, 2024

Biotech Steals The Show Following Pre-Clinical Data Announcement - MSN

Sep 10, 2024
pulisher
Sep 05, 2024

Lixte Biotechnology Holdings Inc (LIXT) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 05, 2024
pulisher
Sep 04, 2024

LIXTLixte Biotechnology Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology - GlobeNewswire

Sep 04, 2024
pulisher
Aug 31, 2024

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Update - Defense World

Aug 31, 2024
pulisher
Aug 28, 2024

Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Aug 28, 2024
pulisher
Aug 27, 2024

Market Recap Check: Lixte Biotechnology Holdings Inc (LIXT)’s Positive Finish at 2.00, Up/Down 11.12 - The Dwinnex

Aug 27, 2024
pulisher
Aug 27, 2024

LIXT Stock: A Voyage Through Lixte Biotechnology Holdings Inc’s Finances - The InvestChronicle

Aug 27, 2024
pulisher
Aug 27, 2024

LIXT stock touches 52-week low at $1.55 amid market fluctuations - Investing.com

Aug 27, 2024
pulisher
Aug 26, 2024

First Patient Dosed with LIXTE’s LB-100 in New Clinical - GlobeNewswire

Aug 26, 2024
pulisher
Aug 26, 2024

First Patient Dosed with Lixte Biotechnology Holdings, Inc.?s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - Marketscreener.com

Aug 26, 2024
pulisher
Aug 26, 2024

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company - StockTitan

Aug 26, 2024
pulisher
Aug 24, 2024

Lixte Biotechnology faces Nasdaq delisting over equity shortfall - Investing.com India

Aug 24, 2024
pulisher
Aug 20, 2024

LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 20, 2024) - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) PS Ratio : (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Inventory-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXTE Biotechnology Provides Update On Recent Activities and Developments - ForexTV.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Purchase Of Investment : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

LIXT (Lixte Biotechnology Holdings) Owner Earnings per Shar - GuruFocus.com

Aug 19, 2024
pulisher
Aug 18, 2024

LIXT (Lixte Biotechnology Holdings) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 18, 2024

LIXT (Lixte Biotechnology Holdings) Debt-to-Equity : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

LIXT (Lixte Biotechnology Holdings) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 17, 2024

LIXT (Lixte Biotechnology Holdings) Effect of Exchange Rate Changes : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 17, 2024
pulisher
Aug 16, 2024

LIXT (Lixte Biotechnology Holdings) Float Percentage Of Tot - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

LIXT (Lixte Biotechnology Holdings) Interest Coverage : 0 (At Loss) (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024
pulisher
Aug 16, 2024

LIXT (Lixte Biotechnology Holdings) Capex-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 16, 2024

Lixte Biotechnology Holdings Inc (LIXT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
大文字化:     |  ボリューム (24 時間):